Eventually a biomarker signature might be developed for diagnosis of ME/CFS: in this context the proportion of CD8+ MAIT cells in peripheral blood had modest discriminatory capacity alone, but might contribute to a combined factor signature. The gene discussed is CD8A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.